XCUR — EXICURE, INC.

—
Nasdaq · Health Care · Pharmaceuticals · CIK 1698530 ·
Last close
$1.08
Market Cap
$7.07M
52W High
$9.48
52W Low
$0.78
ADV30
82,168
Next earnings
—

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Jun 2026 0 — -1,063,000 -1,121,000 11,397,000 1,717,000 10,420,000
Mar 2026 0 — -1,603,000 -1,828,000 12,755,000 2,604,000 10,657,000
Dec 2025 0 — -2,256,000 -2,898,000 14,041,000 3,746,000 10,115,000
Sep 2025 0 — -2,387,000 -2,437,000 15,267,000 4,438,000 8,340,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-6,704,000
Investing CF
$563,000
Financing CF
$0
CapEx
—
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-1.27
As of
2026-11-15

Balance + Analyst (yfinance extras)

Retained Earnings
$-207,159,000
Inventory
—
Receivables
$8,000
ST Investments
—
EBIT TTM
$-8,634,000
Pretax Income TTM
$-8,918,000
Interest Exp TTM
$1,000
Analysts
—

Annual Trend (SEC EDGAR, last 5y)

Revenues vs Net Income (last 5y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 0 -10,117,000 -4,946,000 14,041,000 10,115,000 3,926,000 -8,555,000
Dec 2024 500,000 -4,949,000 -9,701,000 15,056,000 8,284,000 6,772,000 -2,910,000
Dec 2023 0 -13,138,000 -16,914,000 11,580,000 8,549,000 3,031,000 -10,357,000
Dec 2022 28,826,000 -1,831,000 -2,582,000 23,328,000 8,406,000 14,922,000 -35,658,000
Dec 2021 — — — — — — —

TTM Snapshot

Revenues TTM
$0
NetIncome TTM
$-8,284,000
OpCashFlow TTM
—
Assets (Latest)
$11,397,000
Forward EPS
$-0.77

Peers — same industry

TickerNameMarket CapLastDaily %
IMRN Immuron Ltd $7.03M $0.87 —
MBRX Moleculin Biotech, Inc. $6.96M $6.83 —
LGVN Longeveron Inc. $6.83M $2.11 —
CURX Curanex Pharmaceuticals Inc $7.37M $4.70 —
CVKD Cadrenal Therapeutics, Inc. $6.71M $1.88 —

News headlines (Yahoo Finance, 1h cache)

Exicure Announces Filing of Notification of Late Filing on Form 12b-25
2026-11-16 21:00 · Yahoo
Exicure, Inc. Announces Agreement to Sell GPC-100 Program Assets to GPCRT Inc. for KRW 6.5 Billion
2026-11-10 20:50 · Yahoo
Exicure Receives Nasdaq Extension to Regain Compliance with Stockholders’ Equity Requirement
2026-09-16 12:00 · Yahoo
Exicure to Settle GPCR Therapeutics Clinical Milestone Payment Through Equity Issuance
2026-08-03 13:24 · Yahoo
Exicure Announces Board and Committee Changes
2026-06-30 12:40 · Yahoo
Summary Notice of Pendency and Proposed Settlement of Stockholder Derivative Actions
2026-04-02 20:01 · Yahoo
Exicure Announces Receipt of Nasdaq Notice Regarding Minimum Stockholders’ Equity Requirement
2026-06-10 20:01 · Yahoo
Exicure Announces Receipt of Nasdaq Delinquency Notice and Filing of Form 10-Q
2026-06-01 20:00 · Yahoo
Exicure Announces Co-Development Agreement with Adbiotech for Burixafor (GPC-100)
2026-04-22 23:54 · Yahoo
Exicure, Inc. Reports Full Year 2025 Financial Results
2026-03-25 20:18 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.